FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034282486> ?p ?o ?g. }

• W3034282486 abstract "Abstract Background Significant nosocomial transmission of SARS-CoV-2 has been demonstrated. Understanding the prevalence of SARS-CoV-2 carriage amongst HCWs at work is necessary to inform the development of HCW screening programmes to control nosocomial spread. Methods Cross-sectional ‘snapshot’ survey from April-May 2020; HCWs recruited from six UK hospitals. Participants self-completed a health questionnaire and underwent a combined viral nose and throat swab, tested by Polymerase Chain Reaction (PCR) for SARS-CoV-2 with viral culture on majority of positive samples. Findings Point prevalence of SARS-CoV-2 carriage across the sites was 2·0% (23/1152 participants), median cycle threshold value 35·70 (IQR:32·42-37·57). 17 were previously symptomatic, two currently symptomatic (isolated anosmia and sore throat); the remainder declared no prior or current symptoms. Symptoms in the past month were associated with threefold increased odds of testing positive (aOR 3·46, 95%CI 1·38-8·67; p=0·008). SARS-CoV-2 virus was isolated from only one (5%) of nineteen cultured samples. A large proportion (39%) of participants reported symptoms in the past month. Interpretation The point-prevalence is similar to previous estimates for HCWs in April 2020, though a magnitude higher than in the general population. Based upon interpretation of symptom history and testing results including viral culture, the majority of those testing positive were unlikely to be infectious at time of sampling. Development of screening programmes must balance the potential to identify additional cases based upon likely prevalence, expanding the symptoms list to encourage HCW testing, with resource implications and risks of excluding those unlikely to be infectious with positive tests. Funding Public Health England. Word Count Research in context Evidence before this study A search of PubMed was performed on 29 th April 2020 to identify other major works in this field, using the search terms (“novel coronavirus” OR “SARS-CoV-2” OR “COVID-19” OR “coronavirus”) AND (“workers” OR “staff”) AND (“testing” OR “screening”) from 31 st December 2019 onwards with no other limits. This search was updated on 10 th May 2020, and in addition reference lists were checked and pre-print papers were shared with us through professional networks. We found three papers commenting on prevalence of asymptomatic/pauci-symptomatic SARS-CoV-2 infection in healthcare workers, with prevalence estimates ranging from 1·1 to 8%. One of these studies explored previous symptoms in depth, though this was based upon a retrospective questionnaire and thus subject to recall bias. None of these studies explored exposures to the SARS-CoV-2 virus, commented on whether participants had been tested prior to the start of the study, or broke down results by staff role. Only one reported on estimated viral load (as inferred from cycle threshold [Ct] value), and none reported attempting viral culture. Added value of this study This is the first published study of which we are aware that has been conducted across multiple sites in England and is therefore potentially more representative of the overall prevalence of SARS-CoV-2 infectivity amongst HCWs in the workplace. We explored symptoms in the preceding month in more depth than previous studies and in addition asked about previous test results and various exposures, also not commented on in other studies. Additionally, we attempted to isolate virus from some PCR-positive samples to look for evidence of infectious virus. Implications of all the available evidence Authors of previous studies have proposed that screening asymptomatic HCWs for SARS-CoV-2 RNA may be beneficial, in addition to screening symptomatic HCWs. Our findings suggest that when prevalence of COVID-19 is very low, routine and repeated screening would be unlikely to have significant value, especially given the majority of participants testing positive in this study were unlikely to be infectious. However, in situations where prevalence levels are high in a particular population or setting, for example in a hospital outbreak, widening the case definition, or screening all HCWs irrespective of symptoms, may be of benefit." @default.
• W3034282486 created "2020-06-19" @default.
• W3034282486 creator A5000378882 @default.
• W3034282486 creator A5002016425 @default.
• W3034282486 creator A5008918515 @default.
• W3034282486 creator A5012710719 @default.
• W3034282486 creator A5021666091 @default.
• W3034282486 creator A5022573277 @default.
• W3034282486 creator A5027928189 @default.
• W3034282486 creator A5030902266 @default.
• W3034282486 creator A5031427623 @default.
• W3034282486 creator A5047333573 @default.
• W3034282486 creator A5049136341 @default.
• W3034282486 creator A5049436136 @default.
• W3034282486 creator A5055194670 @default.
• W3034282486 creator A5056650171 @default.
• W3034282486 creator A5066019954 @default.
• W3034282486 creator A5067682457 @default.
• W3034282486 creator A5070422979 @default.
• W3034282486 creator A5073413119 @default.
• W3034282486 creator A5079173252 @default.
• W3034282486 creator A5080480753 @default.
• W3034282486 creator A5081186229 @default.
• W3034282486 creator A5081634387 @default.
• W3034282486 creator A5088110666 @default.
• W3034282486 date "2020-06-16" @default.
• W3034282486 modified "2023-10-01" @default.
• W3034282486 title "Snapshot PCR Surveillance for SARS-CoV-2 in Hospital Staff in England" @default.
• W3034282486 cites W3013156767 @default.
• W3034282486 cites W3013994565 @default.
• W3034282486 cites W3014913881 @default.
• W3034282486 cites W3015571324 @default.
• W3034282486 cites W3019252156 @default.
• W3034282486 cites W3019291397 @default.
• W3034282486 cites W3019316334 @default.
• W3034282486 cites W3022275710 @default.
• W3034282486 cites W3027829318 @default.
• W3034282486 cites W3027987830 @default.
• W3034282486 cites W3031807710 @default.
• W3034282486 cites W3165656738 @default.
• W3034282486 doi "https://doi.org/10.1101/2020.06.14.20128876" @default.
• W3034282486 hasPublicationYear "2020" @default.
• W3034282486 type Work @default.
• W3034282486 sameAs 3034282486 @default.
• W3034282486 citedByCount "2" @default.
• W3034282486 countsByYear W30342824862021 @default.
• W3034282486 countsByYear W30342824862022 @default.
• W3034282486 crossrefType "posted-content" @default.
• W3034282486 hasAuthorship W3034282486A5000378882 @default.
• W3034282486 hasAuthorship W3034282486A5002016425 @default.
• W3034282486 hasAuthorship W3034282486A5008918515 @default.
• W3034282486 hasAuthorship W3034282486A5012710719 @default.
• W3034282486 hasAuthorship W3034282486A5021666091 @default.
• W3034282486 hasAuthorship W3034282486A5022573277 @default.
• W3034282486 hasAuthorship W3034282486A5027928189 @default.
• W3034282486 hasAuthorship W3034282486A5030902266 @default.
• W3034282486 hasAuthorship W3034282486A5031427623 @default.
• W3034282486 hasAuthorship W3034282486A5047333573 @default.
• W3034282486 hasAuthorship W3034282486A5049136341 @default.
• W3034282486 hasAuthorship W3034282486A5049436136 @default.
• W3034282486 hasAuthorship W3034282486A5055194670 @default.
• W3034282486 hasAuthorship W3034282486A5056650171 @default.
• W3034282486 hasAuthorship W3034282486A5066019954 @default.
• W3034282486 hasAuthorship W3034282486A5067682457 @default.
• W3034282486 hasAuthorship W3034282486A5070422979 @default.
• W3034282486 hasAuthorship W3034282486A5073413119 @default.
• W3034282486 hasAuthorship W3034282486A5079173252 @default.
• W3034282486 hasAuthorship W3034282486A5080480753 @default.
• W3034282486 hasAuthorship W3034282486A5081186229 @default.
• W3034282486 hasAuthorship W3034282486A5081634387 @default.
• W3034282486 hasAuthorship W3034282486A5088110666 @default.
• W3034282486 hasBestOaLocation W30342824861 @default.
• W3034282486 hasConcept C126322002 @default.
• W3034282486 hasConcept C141071460 @default.
• W3034282486 hasConcept C142052008 @default.
• W3034282486 hasConcept C142724271 @default.
• W3034282486 hasConcept C156725737 @default.
• W3034282486 hasConcept C156957248 @default.
• W3034282486 hasConcept C159047783 @default.
• W3034282486 hasConcept C166888038 @default.
• W3034282486 hasConcept C177713679 @default.
• W3034282486 hasConcept C194828623 @default.
• W3034282486 hasConcept C2522874641 @default.
• W3034282486 hasConcept C2776989088 @default.
• W3034282486 hasConcept C2777870961 @default.
• W3034282486 hasConcept C2779134260 @default.
• W3034282486 hasConcept C2908647359 @default.
• W3034282486 hasConcept C3007834351 @default.
• W3034282486 hasConcept C3008058167 @default.
• W3034282486 hasConcept C32762888 @default.
• W3034282486 hasConcept C524204448 @default.
• W3034282486 hasConcept C71924100 @default.
• W3034282486 hasConcept C99454951 @default.
• W3034282486 hasConceptScore W3034282486C126322002 @default.
• W3034282486 hasConceptScore W3034282486C141071460 @default.
• W3034282486 hasConceptScore W3034282486C142052008 @default.
• W3034282486 hasConceptScore W3034282486C142724271 @default.
• W3034282486 hasConceptScore W3034282486C156725737 @default.
• W3034282486 hasConceptScore W3034282486C156957248 @default.
• W3034282486 hasConceptScore W3034282486C159047783 @default.

• next